Sarepta Therapeutics (SRPT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Sarepta Therapeutics (SRPT) reported $467.17 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 40.8%. EPS of $0.62 for the same period compares to -$0.46 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $399.88 million, representing a surprise of +16.83%. The company delivered an EPS surprise of +513.33%, with the consensus EPS estimate being -$0.15.While investors closely watch year-over-year changes in headline numbers -- revenue ...